Trial Profile
Once-daily Regimen With Envarsus to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil (Primary) ; Prednisone (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 09 Sep 2019 Status changed from active, no longer recruiting to completed.
- 29 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 10 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Jan 2019.